Stocks & Investing
Fri, October 4, 2024
[ Fri, Oct 04th 2024
] - WOPRAI
Fri, August 30, 2024
[ Fri, Aug 30th 2024
] - WOPRAI
Tue, August 13, 2024
[ Tue, Aug 13th 2024
] - WOPRAI
Fri, August 9, 2024
[ Fri, Aug 09th 2024
] - WOPRAI
Thu, July 25, 2024
[ Thu, Jul 25th 2024
] - WOPRAI
[ Thu, Jul 25th 2024
] - WOPRAI
Thu, June 20, 2024
[ Thu, Jun 20th 2024
] - WOPRAI
Wed, March 20, 2024
[ Wed, Mar 20th 2024
] - WOPRAI
Fri, February 23, 2024
[ Fri, Feb 23rd 2024
] - WOPRAI
Thu, December 7, 2023
[ Thu, Dec 07th 2023
] - WOPRAI
Caitlin Cronin Maintained (TELA) at Strong Buy and Held Target at $12 on, Oct 4th, 2024
Caitlin Cronin of Canaccord Genuity, Maintained "TELA Bio, Inc." (TELA) at Strong Buy and Held Target at $12 on, Oct 4th, 2024.
Caitlin has made no other calls on TELA in the last 4 months.
There are 3 other peers that have a rating on TELA. Out of the 3 peers that are also analyzing TELA, 0 agree with Caitlin's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Caitlin
- David Turkaly of "JMP Securities" Maintained at Buy with Decreased Target to $12 on, Tuesday, August 13th, 2024
- Frank Takkinen of "Lake Street" Maintained at Strong Buy with Decreased Target to $8 on, Tuesday, August 13th, 2024
- Matt O'Brien of "Piper Sandler" Maintained at Buy with Decreased Target to $8 on, Tuesday, August 13th, 2024
